Search Results
Aug 18, 2026, 08:30 ET BioMarin to Acquire Alesta Therapeutics to Gain ALE1, a Potential First Oral Therapy for Hypophosphatasia, Adding an Important Clinical Program to BioMarin's Pipeline
chose to partner with BioMarin due to their deep commitment to people living with rare diseases," said Ilan Ganot, Chief Executive Officer of Alesta Therapeutics. "BioMarin's global reach, scale, and proven expertise in rare disease drug development make it an ideal partner to advance ALE1 and realize its
More news about: BioMarin Pharmaceutical Inc.
Aug 18, 2026, 08:07 ET Nine Ocean Tomo Experts Named to the 2026 IAM Strategy 300 - The World's Leading Intellectual Property Strategists
career extracting commercial value from intellectual property. Equally experienced in valuation, licensing, FRAND analysis, and damages, he brings a rare operator's perspective to complex patent transactions and business-critical disputes across technology-driven industries." -- IAM Strategy 300Ozer
More news about: J.S. Held
Aug 18, 2026, 08:03 ET Veteran Therapist and Adopted Son Offer Rare Dual Perspective on Trauma and Systemic Reform
multimedia:https://www.prnewswire.com/news-releases/veteran-therapist-and-adopted-son-offer-rare-dual-perspective-on-trauma-and-systemic-reform-302854062.htmlSOURCE
More news about: Linda Ford Ayres
Aug 18, 2026, 08:00 ET Kedrion Biopharma Announces the Extension of a U.S. Agreement with Grifols to Support Long-Term and Continued Access to GAMMAKED®
Inc.About Kedrion Kedrion Biopharma collects and fractionates blood plasma to produce and distribute plasma‑derived therapies for rare, ultra‑rare, and debilitating conditions, including coagulation and neurological disorders, immunodeficiencies, and Rh sensitization. We employ approximately
More news about: Kedrion Biopharma
Aug 18, 2026, 08:00 ET Pure Financial Advisors Adds New President
"Eugene possesses a rare blend of operating expertise and direct experience as a financial advisor, a combination that makes him particularly well qualified to help lead Pure
More news about: Pure Financial Advisors, LLC
Aug 18, 2026, 08:00 ET The Alliance Group Marks 10 Consecutive Years on the Inc. 5000 List of America's Fastest-Growing Private Companies
Each year, only 5,000 companies nationwide earn a spot on the Inc. 5000. Earning that distinction for ten years in a row places Alliance in truly rare company: according to Inc. 5000 reporting for 2026, only 96 companies have made the list 10 or more times. That milestone reflects a decade of
More news about: The Alliance Group
Aug 18, 2026, 08:00 ET Silvercorp Announces Main Zone Drill Results, Including 1.68 g/t Gold over 212.5 Metres, at the Kyzyltash Sulfide Gold Project, Kyrgyzstan
Under Canadian securities laws, estimates of "inferred mineral resources" may not form the basis of feasibility or pre-feasibility studies, except in rare cases. While the above terms under the U.S. Rules are "substantially similar" to the standards under NI 43-101 and CIM Standards, there are differences
More news about: Silvercorp Metals Inc.
Aug 18, 2026, 07:13 ET Diesel Laptops and Trucker Path Announce Exclusive Limited-Time Diagnostic and Navigation Bundle for Truckers
comprehensive and relied upon mobile app for North American truckers, have launched a limited-time promotion, offering owner-operators and small fleets a rare opportunity to significantly reduce equipment downtime and operational costs. By combining professional grade diagnostic hardware with truck specific
More news about: Trucker Path
Aug 18, 2026, 06:50 ET Jaguar Uranium Reports Final Copper Assay Results Including up to 8.54% Copper, Potential 4-km Trend Identified from Huemul Uranium-Copper-Vanadium Project
Berlin Project in Caldas Province, Colombia is a district-scale, sedimentary-hosted polymetallic system historically reported to host uranium alongside rare earth elements, vanadium, nickel, phosphate, molybdenum, rhenium and zinc. Jaguar completed a $25 million initial public offering on NYSE American in
More news about: Jaguar Uranium
Aug 18, 2026, 06:17 ET CAPR Stock News: Capricor Therapeutics Sued for Securities Fraud over Alleged Misrepresentations and Corresponding 64% Stock Drop
Sued for Securities Fraud? Capricor is a biotechnology company focused on developing cell and exosome-based therapeutics for rare diseases. Its lead product candidate, Deramiocel, is an investigational cell therapy being developed for Duchenne muscular dystrophy.According
More news about: Bleichmar Fonti & Auld LLP
Aug 18, 2026, 02:20 ET STARTRADER、AI関連商品のラインアップを拡充。半導体、光通信ネットワーク、原子力分野にわたる31銘柄の米国株CFD・ETF CFDを新たに追加
Optoelectronics、Fabrinetは光通信ネットワーク分野を対象としており、Centrus EnergyとNuScale Powerは原子力エネルギー分野へのエクスポージャーを提供します。さらに、Nokia、EchoStar、USA Rare Earth、Nebius、Iris Energyがラインアップに加わります。7銘柄のETF CFDは、半導体（SMH、SOX
More news about: STARTRADER
Aug 18, 2026, 00:30 ET Zydus Hospitals Sets New Benchmarks in High-Risk Pregnancy and Complex Gynaecological Care
Her first child was born by C-section. During the scans, we could see her placenta had invaded deeply into the uterine wall, and found that she had a rare condition known as placenta accreta spectrum along with placenta previa."Placenta previa becomes considerably more serious when combined with
More news about: Zydus Hospitals and Healthcare Research Private Limited
Aug 17, 2026, 18:10 ET Resolve AI Appoints Jason Forget as President and Founding Chief Revenue Officer
University and a Bachelor of Science in finance and marketing from Northeastern University."As I thought about my next move, I looked for the rare intersection of exceptional founders and people, a consequential customer problem, and the cutting edge of the industry helping shape the AI revolution
More news about: Resolve AI
Aug 17, 2026, 16:02 ET Duke Energy thanks Greater Cincinnati customers for their patience and support as storm workers restored power after rare derecho
caused further outages and slowed power restoration efforts.According to the National Weather Service, a derecho is a rare, widespread, long-lived windstorm associated with fast-moving thunderstorms. It can produce damage similar to a tornado, but typically along a broad,
More news about: Duke Energy
Aug 17, 2026, 11:30 ET America250 Backs College Entrepreneurs with Re-Opening of "America's Startup" National Competition
opportunity, the competition's major highlight is an immersive, once-in-a-lifetime Pitch Weekend in mid-December—giving emerging collegiate entrepreneurs the rare opportunity to step into the spotlight and pitch their boldest visions face-to-face before an illustrious panel of legendary business leaders, venture
More news about: America250
Aug 17, 2026, 10:41 ET Once Upon A Coconut Partners With Professional Basketball Star Sophie Cunningham to Champion Coconut Water With a Purpose
compassion and camaraderie. She can compete at the highest level and stand up for her teammates while always embracing who she is. That combination is rare. Most importantly, she doesn't try to be anybody other than herself. That authenticity is incredibly powerful."The partnership represents a major
More news about: Once Upon a Coconut
Aug 17, 2026, 09:00 ET Hilco Global Appoints Industry Veteran Andrew Hede as Vice Chairman of Hilco Global Professional Services
connect clients and strategic partners to the company's full range of capabilities."Andrew is a highly accomplished operator and advisor with a rare ability to bridge strategy and execution," said Mr. Kurtz. "His leadership, deep relationships and ability to originate across disciplines will be instrumental
More news about: Hilco Trading, LLC
Aug 17, 2026, 09:00 ET La Roche-Posay Announces 2025 Young Investigator Grant Winners and Opens Applications for 2026 Program
says Jessica Allison, AVP of Medical Relations at La Roche-Posay. "This year's projects range from broad scale Teledermatology to foundational studies in rare diseases. By supporting these innovative researchers, we are playing a vital role in shaping the future of accessible, effective, and evidence-based
More news about: La Roche-Posay
Aug 17, 2026, 09:00 ET Slingshot Bio Launches ViaComp® Ultra Amine: A Next-Generation Cell Mimic for Amine-Reactive Viability and Antibody Compensation in Multiparameter Flow Cytometry
donor-derived PBMCs, and polystyrene beads present ongoing challenges including lot-to-lot variability, resource-intensive maintenance, limited availability for rare biomarkers, and regulatory burden.Slingshot Bio's cell mimic platform addresses these challenges by combining the biological relevance of cell-based
More news about: Slingshot Bio
Aug 17, 2026, 08:30 ET Access Program Process Changes to Increase Speed to Therapy, Upcoming Webinar Hosted by Xtalks
In this free webinar, learn how pharmaceutical teams can evaluate access program processes and hub vendors to help reduce delays in specialty and rare disease therapies. The featured speaker will discuss key operational questions, performance metrics and the role of automation in access workflows.
More news about: Xtalks
Aug 17, 2026, 08:30 ET Running Paediatric Gene Therapy Studies: Operations and Oversight in Practice, Upcoming Webinar Hosted by Xtalks
TORONTO, Aug. 17, 2026 /PRNewswire/ -- Gene therapy is changing what is possible in paediatric rare disease, but the distance between a sound protocol and a study that delivers for patients is closed through execution. Patient populations are small
More news about: Xtalks
Aug 17, 2026, 07:38 ET American Red Cross launches multi-year fundraising campaign to strengthen nation's blood supply
effort.""Getting blood from a donor to a patient isn't as simple as people might think. The amount of sophisticated equipment for testing and some of the rare donor programs is a highly technical process that needs a lot of investment," said Teresa Pollitt. "No one ever knows when the need is going to be there
More news about: American Red Cross
Aug 17, 2026, 07:29 ET WeBrokr Advises MyGolfSpy on Strategic Investment from Graham Sports & Entertainment Partners and Bolt Ventures
further acquisitions across golf media, data, and experiences."Golf has always been the sport closest to my heart, and MyGolfSpy was one of those rare deals where you feel a personal stake in getting the outcome right for the founder," said Logan Abner, Founder of WeBrokr. "Adam Beach built something
More news about: WeBrokr, LLC
Aug 17, 2026, 06:00 ET Inspire Makes Inc. 5000 List For the Seventh Year in A Row
Earning a place on the Inc. 5000 for seven consecutive years is a rare achievement that reflects sustained excellence in growth and execution. Because the list is based on rolling three-year revenue growth, companies must
More news about: Inspire Investing
Aug 16, 2026, 22:00 ET Cognizant and Benchling Selected as Partners to Accelerate Kyowa Kirin's R&D
pharmaceutical company with strengths in specific disease areas, including bone and mineral disorders, intractable hematologic diseases and hemato oncology and rare diseases. At its three research facilities worldwide, the company is pursuing innovative modalities such as advanced antibody technologies and hematopoietic
More news about: Cognizant Technology Solutions